AD |
Alzheimer’s disease |
ADC |
adenocarcinoma |
AMP |
antimicrobial peptide |
ANT |
adenine nucleotide translocator |
ATP |
adenosine triphosphate |
Bcl-2 |
namely B-cell lymphoma 2 |
Bcl-xL |
B-cell lymphoma extra-large |
Ca2+
|
calcium ion |
Cacy/SIP |
calcyclin-binding protein/Siah-1-interacting protein |
CCL2 |
chemokine (C-C motif) ligand 2 |
COP9 |
constitutive photomorphogenesis 9 |
COPS5 |
COP9 constitutive photomorphogenic homolog subunit 5 |
COX2 |
cyclooxygenase-2 |
CP |
calprotectin |
CRC |
colorectal carcinoma |
CT |
computerised tomography |
Cu2+
|
copper ion |
CXCL |
chemokine (C-X-C motif) ligand |
DAMPs |
danger-associated molecular patterns DAMPs |
ECG |
electrocardiogram |
ECM |
extracellular matrix |
EDC |
epidermal differentiation complex |
EGF |
epidermal growth factor |
EMMPRIN |
extracellular matrix metalloprotease inducer |
EMT |
epithelial-mesenchymal transition |
ERK |
extracellular signal-regulated kinase |
ERα |
in estrogen receptor α |
FABP |
fatty acid-binding proteins |
FAK |
focal adhesion kinase |
FDA |
Food and Drug Administration |
Fe2+
|
iron ion |
HCC |
hepatocellular carcinoma |
HIF-1 |
hypoxia-inducible factor 1 |
IBD |
inflammatory bowel disease |
ICI |
intracranial injuries |
IL-1β |
interleukin-1β |
IFN-γ |
interferon gamma |
Jab1 |
c-Jun activation domain-binding protein-1 |
MAPK |
mitogen-activated protein kinase |
MAP3K8 |
mitogen-activated protein kinase kinase kinase 8 |
MCAM |
melanoma cell adhesion molecule |
MDR1 |
multidrug resistance gene 1 |
Mef2 |
myocyte enhancer factor-2 |
MRP1 |
MDR-associated protein 1 |
miRNA |
micro RNA |
MMP |
metalloproteinase |
Mn2+
|
manganese ion |
mTOR |
mechanistic target of rapamycin |
NCX1 |
Na+/Ca2+ exchanger |
Ndr |
nuclear dbf2-related |
NF-kB |
nuclear factor ’kappa-light-chain-enhancer’ of activated B-cells |
NMIBC |
non-muscle-invasive bladder cancer |
NMIIA |
non-muscle myosin heavy chain IIA |
NOXA |
phorbol-12-myristate-13-acetate-induced protein 1 |
NSCLC |
non-small cell lung cancer |
OS |
overall survival |
OCSC |
ovarian cancer stem cells |
PAD3 |
phytoalexin deficient 3 |
PDGF |
platelet-derived growth factor |
PI3K |
phosphoinositide 3-kinase |
PMCA1b |
plasma membrane Ca2+ transport ATPase |
PUMA |
p53 upregulated modulator of apoptosis |
RA |
rheumatoid arthritis |
RAGE |
receptor for advanced glycation end products |
ROS |
reactive oxygen species |
RSK |
ribosomal S6 kinase |
RyR2 |
ryanodine receptor 2 |
SCC |
squamous-cell carcinoma |
SCLC |
small cell lung cancer |
SERCA2a |
sarcoplasmic reticulum ATPase |
Shh |
sonic hedgehog |
SNC |
Scandinavian Neurotrauma Committee |
STEMI |
ST-segment elevation myocardial infarction |
TAMs |
tumour-associated macrophages |
TBA |
traumatic brain injury |
TCF |
T-cell factor |
TLR4 |
Toll-like receptor 4 |
TME |
tumour microenvironment |
TNFα |
tumour necrosis factor α |
tPA |
tissue plasminogen activator |
TPL2 |
tumour progression locus 2 |
TRAF |
TNF receptor-associated factor 2 |
TRAIL |
tumour necrosis factor-related apoptosis-inducing ligand |
TRPV6 |
transient receptor potential vanilloid 6 |
VEGF |
vascular endothelial growth factor |
YAP |
yes-associated protein |
Zn2+
|
zinc ion |